Please do not leave this page until complete. This can take a few moments.
Germany-based biotech firm Boehringer Ingelheim, which has its U.S. headquarters in Ridgefield, has acquired Nerio Therapeutics Inc., aCalifornia-based oncology biotech, for $1.3 billion, the company said recently.
Rallybio, a New Haven-based biotechnology firm, said Tuesday its co-founder and executive chairman will resign at the end of the year.
Paris pharmaceutical giant Sanofi established a Connecticut presence in 2017 when it acquired a poster child of the state’s nascent bioscience industry, Protein Sciences Corp., in a deal valued at $750 million.
Paris pharmaceutical giant Sanofi established a Connecticut presence in 2017 when it acquired a poster child of the state’s nascent bioscience industry, Protein Sciences Corp., in a deal valued at $750 million.
MannKind Corp., a biopharmaceutical company based in Danbury, on Saturday announced positive results from a study that showed inhaling insulin is as effective as injecting it for treating adults with Type 1 diabetes.
Peter J. Werth, founder of a Woodbridge-based supplier and developer of generic drug ingredients, announced Monday he will be stepping down as president and CEO of ChemWerth.
Three bioscience companies have signed leases to operate out of the Elm City Bioscience Center in New Haven.
Biohaven Pharmaceuticals Inc. has purchased another downtown New Haven property next to its main headquarters as it continues expanding throughout the Elm City.
Thousands of people across Connecticut live with chronic conditions such as cancer, arthritis or hemophilia and rely on prescription drugs to manage their health.
Regeneron Ventures, a Greenwich-based biotech venture capital fund, announced Monday it has launched with a five-year, $500 million commitment from its exclusive limited partner Regeneron Pharmaceuticals.
New Haven-based biotech Arvinas Inc. has signed a licensing agreement with Swiss drugmaker Novartis AG that could be worth up to $1.01 billion, the company announced Thursday.
Purdue Pharma has asked the federal Food and Drug Administration (FDA) to approve a new, auto-injectable form of one of its drugs to treat opioid overdoses.
MannKind Corp., a Danbury-based company that develops inhaled therapeutic products, has named a new chief financial officer.
BioXcel Therapeutics Inc., a New Haven-based biopharmaceutical company that uses artificial intelligence to develop medicines in neuroscience and immuno-oncology, on Monday announced a $25 million registered direct offering.
Arvinas Inc. has appointed Dr. Noah Berkowitz as chief medical officer and added him to its executive committee, the New Haven-based biotech company said this week.
A nonprofit biotechnology company formerly based in Boston will celebrate its relocation to Connecticut this weekend.
Powered by UHY
Connecticut has tried to attract more data centers by creating tax incentives through the state Department of Economic and Community Development.
In 2021, the legislature enacted the Connecticut Data Center Tax Incentive Program, which can waive sales and use, and property taxes for 20 years for data centers that invest at least $200 million ($50 million if located within a state-designated enterprise zone).
The tax exemptions could be extended up to 30 years for investments that exceed $400 million.
So far, Bloomfield-based health insurer Cigna Group is the only company to apply for benefits under the program.
Some states offer additional incentives to promote data center growth, including New York’s ReCharge NY, which subsidizes power for businesses.
Data center operators say Connecticut’s high costs of electricity, real estate and wages make the cost of running a data center less lucrative than in nearby states, even with the current incentives in place.
The Hartford Business Journal 2025 Charity Event Guide is the annual resource publication highlighting the top charity events in 2025.
Learn moreHartford Business Journal provides the top coverage of news, trends, data, politics and personalities of the area’s business community. Get the news and information you need from the award-winning writers at HBJ. Don’t miss out - subscribe today.
SubscribeDelivering vital marketplace content and context to senior decision-makers throughout Connecticut ...
All Year Long!
The Hartford Business Journal 2025 Charity Event Guide is the annual resource publication highlighting the top charity events in 2025.
Hartford Business Journal provides the top coverage of news, trends, data, politics and personalities of the area’s business community. Get the news and information you need from the award-winning writers at HBJ. Don’t miss out - subscribe today.
Delivering vital marketplace content and context to senior decision-makers throughout Connecticut ...
All Year Long!
In order to use this feature, we need some information from you. You can also login or register for a free account.
By clicking submit you are agreeing to our cookie usage and Privacy Policy
Already have an account? Login
Already have an account? Login
Want to create an account? Register
This website uses cookies to ensure you get the best experience on our website. Our privacy policy
To ensure the best experience on our website, articles cannot be read without allowing cookies. Please allow cookies to continue reading. Our privacy policy